Peter E Kima
Overview
Explore the profile of Peter E Kima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
559
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
da Silva D, Sharjeel A, Beliakoff R, Teixeira L, Kima P, Jones M, et al.
Front Immunol
. 2024 Dec;
15:1490755.
PMID: 39712028
The internalization of N6.2 extracellular vesicles (EVs) by cells results in a significant induction of the 2',5'-oligoadenylate synthetase (OAS) pathway. It also induces expression of and . In this work,...
2.
Kima P
Trends Parasitol
. 2023 Sep;
39(11):900-901.
PMID: 37743113
The capacity to infect and survive in a wide variety of host cells is amongst the strategies that contribute to pathogen persistence. The recent study by Karagiannis et al. presents...
3.
Gruntmeir J, Abbott J, Kima P, Long M, Blagburn B, Walden H
Parasit Vectors
. 2023 Apr;
16(1):152.
PMID: 37106356
Background: Immune complexing of target antigen to high affinity host antibody is recognized to impact the sensitivity of commercial heartworm antigen tests. Published information describing the effect of heat on...
4.
Edelmann M, Kima P
Zoonoses (Burlingt)
. 2022 May;
2.
PMID: 35601996
Extracellular vesicles (EVs) are membrane-enclosed packets released from cells that can transfer bioactive molecules from cell to cell without direct contact with the target cells. This transfer of molecules can...
5.
Craig E, Calarco A, Conte R, Ambrogi V, Gomez dAyala G, Alabi P, et al.
Front Cell Infect Microbiol
. 2021 Sep;
11:702676.
PMID: 34490142
Clinical manifestations of leishmaniasis range from self-healing, cutaneous lesions to fatal infections of the viscera. With no preventative vaccine available, the frontline option against leishmaniasis is chemotherapy. Unfortunately, currently available...
6.
Gioseffi A, Edelmann M, Kima P
Front Immunol
. 2021 May;
12:662944.
PMID: 33959131
Extracellular vesicles (EVs) have garnered significant interest in recent years due to their contributions to cell-to-cell communication and disease processes. EVs are composed of a complex profile of bioactive molecules,...
7.
Gioseffi A, Hamerly T, Van K, Zhang N, Dinglasan R, Yates P, et al.
Life Sci Alliance
. 2020 Oct;
3(12).
PMID: 33122174
infection of macrophages results in quantitative and qualitative changes in the protein profile of extracellular vesicles (EVs) released by the infected host cells. We confirmed mass spectrometry results orthogonally by...
8.
Galvao J, Santos R, Silva A, Santos J, Costa A, Chandasana H, et al.
Eur J Pharm Sci
. 2020 Apr;
150:105335.
PMID: 32272211
Leishmaniasis are a group of neglected infectious diseases caused by protozoa of the genus Leishmania with distinct presentations. The available leishmaniasis treatment options are either expensive and/or; cause adverse effects...
9.
Young J, Kima P
Yale J Biol Med
. 2019 Sep;
92(3):511-521.
PMID: 31543712
The parasitophorous vacuole membrane (LPVM) sits at the interface of the parasite and its host. Evidence shows that molecules from the endocytic pathway as well as molecules from the secretory...
10.
Nandan D, Zhang N, Yu Y, Schwartz B, Chen S, Kima P, et al.
PLoS One
. 2018 Nov;
13(11):e0206920.
PMID: 30399177
Leishmaniasis is amongst the most important neglected diseases, afflicting more than 12 million people in 88 countries. There is an urgent need for safe orally bioavailable and cost-effective drugs for...